ACE and coronary artery disorder: In a meta-analysis of randomized controlled trials, patients with no obstructive CAD treated with angiotensin converting enzyme inhibitors (ACE-Is) had improvement in endothelial function measured by brachial artery flow-mediated dilation [21].